Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design
Само за регистроване кориснике
2017
Аутори
Bouchet, SamuelLinot, Camille
Ružić, Dušan
Agbaba, Danica
Fouchaq, Benoit
Roche, Joëlle
Nikolić, Katarina
Cuendet, Muriel
Ovádi, Judit
Blanquart, Christophe
Bertrand, Philippe
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуИзвор:
EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017, 2017, 19-19Издавач:
- European Cooperation in Science and Technology (COST)
Финансирање / пројекти:
- Синтеза, квантитативни однос између структуре и дејства, физичко-хемијска карактеризација и анализа фармаколошки активних супстанци (RS-MESTD-Basic Research (BR or ON)-172033)
Напомена:
- Joint Annual Meeting 2017, BOOK OF THE ABSTRACTS
Институција/група
PharmacyTY - CONF AU - Bouchet, Samuel AU - Linot, Camille AU - Ružić, Dušan AU - Agbaba, Danica AU - Fouchaq, Benoit AU - Roche, Joëlle AU - Nikolić, Katarina AU - Cuendet, Muriel AU - Ovádi, Judit AU - Blanquart, Christophe AU - Bertrand, Philippe PY - 2017 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4926 PB - European Cooperation in Science and Technology (COST) C3 - EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017 T1 - Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design SP - 19 EP - 19 UR - https://hdl.handle.net/21.15107/rcub_farfar_4926 ER -
@conference{ author = "Bouchet, Samuel and Linot, Camille and Ružić, Dušan and Agbaba, Danica and Fouchaq, Benoit and Roche, Joëlle and Nikolić, Katarina and Cuendet, Muriel and Ovádi, Judit and Blanquart, Christophe and Bertrand, Philippe", year = "2017", publisher = "European Cooperation in Science and Technology (COST)", journal = "EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017", title = "Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design", pages = "19-19", url = "https://hdl.handle.net/21.15107/rcub_farfar_4926" }
Bouchet, S., Linot, C., Ružić, D., Agbaba, D., Fouchaq, B., Roche, J., Nikolić, K., Cuendet, M., Ovádi, J., Blanquart, C.,& Bertrand, P.. (2017). Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design. in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017 European Cooperation in Science and Technology (COST)., 19-19. https://hdl.handle.net/21.15107/rcub_farfar_4926
Bouchet S, Linot C, Ružić D, Agbaba D, Fouchaq B, Roche J, Nikolić K, Cuendet M, Ovádi J, Blanquart C, Bertrand P. Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design. in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017. 2017;:19-19. https://hdl.handle.net/21.15107/rcub_farfar_4926 .
Bouchet, Samuel, Linot, Camille, Ružić, Dušan, Agbaba, Danica, Fouchaq, Benoit, Roche, Joëlle, Nikolić, Katarina, Cuendet, Muriel, Ovádi, Judit, Blanquart, Christophe, Bertrand, Philippe, "Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design" in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017 (2017):19-19, https://hdl.handle.net/21.15107/rcub_farfar_4926 .